2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Publication
, Journal Article
Levine, GN; Bates, ER; Bittl, JA; Brindis, RG; Fihn, SD; Fleisher, LA; Granger, CB; Lange, RA; Mack, MJ; Mauri, L; Mehran, R; Mukherjee, D ...
Published in: J Am Coll Cardiol
September 6, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
September 6, 2016
Volume
68
Issue
10
Start / End Page
1082 / 1115
Location
United States
Related Subject Headings
- Time Factors
- Purinergic P2Y Receptor Antagonists
- Platelet Aggregation Inhibitors
- Humans
- Coronary Artery Disease
- Cardiovascular System & Hematology
- Aspirin
- Algorithms
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., … Smith, S. C. (2016). 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 68(10), 1082–1115. https://doi.org/10.1016/j.jacc.2016.03.513
Levine, Glenn N., Eric R. Bates, John A. Bittl, Ralph G. Brindis, Stephan D. Fihn, Lee A. Fleisher, Christopher B. Granger, et al. “2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.” J Am Coll Cardiol 68, no. 10 (September 6, 2016): 1082–1115. https://doi.org/10.1016/j.jacc.2016.03.513.
Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016 Sep 6;68(10):1082–115.
Levine, Glenn N., et al. “2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.” J Am Coll Cardiol, vol. 68, no. 10, Sept. 2016, pp. 1082–115. Pubmed, doi:10.1016/j.jacc.2016.03.513.
Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O’Gara PT, Sabatine MS, Smith PK, Smith SC. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016 Sep 6;68(10):1082–1115.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
September 6, 2016
Volume
68
Issue
10
Start / End Page
1082 / 1115
Location
United States
Related Subject Headings
- Time Factors
- Purinergic P2Y Receptor Antagonists
- Platelet Aggregation Inhibitors
- Humans
- Coronary Artery Disease
- Cardiovascular System & Hematology
- Aspirin
- Algorithms
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services